Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$277.31M
↑ 195% above average
Average (9y)
$94.01M
Historical baseline
Range
High:$277.31M
Low:$3.88M
CAGR
+60.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $277.31M | +15.4% |
| 2023 | $240.29M | +64.4% |
| 2022 | $146.16M | +31.0% |
| 2021 | $111.56M | +269.5% |
| 2020 | $30.19M | -62.9% |
| 2019 | $81.47M | +1092.3% |
| 2018 | $6.83M | -42.6% |
| 2017 | $11.90M | -61.0% |
| 2016 | $30.53M | +688.0% |
| 2015 | $3.88M | - |